Chargement en cours...
Distinguishing Patients With Distant Metastatic Differentiated Thyroid Cancer Who Biochemically Benefit From Next Radioiodine Treatment
BACKGROUND: Repeated radioiodine ((131)I) treatment (RT) are commonly performed in patients with (131)I-avid distant metastatic differentiated thyroid cancer (DM-DTC), but more precise indications remain indeterminate. This prospective study was conducted to explore predictors for biochemical respon...
Enregistré dans:
| Publié dans: | Front Endocrinol (Lausanne) |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Frontiers Media S.A.
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7701118/ https://ncbi.nlm.nih.gov/pubmed/33304320 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2020.587315 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|